119 related articles for article (PubMed ID: 19454675)
1. Teleost B7 expressed on monocytes regulates T cell responses.
Sugamata R; Suetake H; Kikuchi K; Suzuki Y
J Immunol; 2009 Jun; 182(11):6799-806. PubMed ID: 19454675
[TBL] [Abstract][Full Text] [Related]
2. The B7 family of immunoregulatory receptors: a comparative and evolutionary perspective.
Hansen JD; Du Pasquier L; Lefranc MP; Lopez V; Benmansour A; Boudinot P
Mol Immunol; 2009 Jan; 46(3):457-72. PubMed ID: 19081138
[TBL] [Abstract][Full Text] [Related]
3. B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production.
Chapoval AI; Ni J; Lau JS; Wilcox RA; Flies DB; Liu D; Dong H; Sica GL; Zhu G; Tamada K; Chen L
Nat Immunol; 2001 Mar; 2(3):269-74. PubMed ID: 11224528
[TBL] [Abstract][Full Text] [Related]
4. Transfection of B7-1 cDNA empowers antigen presentation of blood malignant cells for activation of anti-tumor T cells.
Ke X; Jia L; Wang J; Wang D
Chin Med J (Engl); 2003 Jan; 116(1):78-84. PubMed ID: 12667394
[TBL] [Abstract][Full Text] [Related]
5. Renal tubular epithelial expression of the coinhibitory molecule B7-DC (programmed death-1 ligand).
Zhang J; Chen Y; Li J; Zhang R; Wu Y; Zou L; Zhao T; Zhang X; Han J; Chen A; Wu Y
J Nephrol; 2006; 19(4):429-38. PubMed ID: 17048200
[TBL] [Abstract][Full Text] [Related]
6. Co-inhibitory role of T-cell-associated B7-H1 and B7-DC in the T-cell immune response.
Seo SK; Seo HM; Jeong HY; Choi IW; Park YM; Yagita H; Chen L; Choi IH
Immunol Lett; 2006 Feb; 102(2):222-8. PubMed ID: 16236366
[TBL] [Abstract][Full Text] [Related]
7. B7-1 and B7-2: similar costimulatory ligands with different biochemical, oligomeric and signaling properties.
Bhatia S; Edidin M; Almo SC; Nathenson SG
Immunol Lett; 2006 Apr; 104(1-2):70-5. PubMed ID: 16413062
[TBL] [Abstract][Full Text] [Related]
8. B cells in teleost fish act as pivotal initiating APCs in priming adaptive immunity: an evolutionary perspective on the origin of the B-1 cell subset and B7 molecules.
Zhu LY; Lin AF; Shao T; Nie L; Dong WR; Xiang LX; Shao JZ
J Immunol; 2014 Mar; 192(6):2699-714. PubMed ID: 24532580
[TBL] [Abstract][Full Text] [Related]
9. The new B7s: playing a pivotal role in tumor immunity.
Flies DB; Chen L
J Immunother; 2007 Apr; 30(3):251-60. PubMed ID: 17414316
[TBL] [Abstract][Full Text] [Related]
10. Hybrid cells formed by fusion of Epstein-Barr virus-associated B-lymphoblastoid cells and either marrow-derived or solid tumour-derived cell lines display different co-stimulatory phenotypes and abilities to activate allogeneic T-cell responses in vitro.
Cywinski AL; Dunnion DJ; Teobald I; Tucker VC; Browning MJ
Tissue Antigens; 2006 Aug; 68(2):115-26. PubMed ID: 16866881
[TBL] [Abstract][Full Text] [Related]
11. Altered expression of the costimulatory molecules CD80, CD86, CD152, PD-1 and ICOS on T-cells from paracoccidioidomycosis patients: lack of correlation with T-cell hyporesponsiveness.
Cacere CR; Mendes-Giannini MJ; Fontes CJ; Kono A; Duarte AJ; Benard G
Clin Immunol; 2008 Nov; 129(2):341-9. PubMed ID: 18757242
[TBL] [Abstract][Full Text] [Related]
12. Modulation of T cell responses after cross-talk between antigen presenting cells and T cells: a give-and-take relationship.
Wauben MH; 't Hoen EN; Taams LS
Novartis Found Symp; 2003; 252():211-20; discussion 220-5, 257-67. PubMed ID: 14609221
[TBL] [Abstract][Full Text] [Related]
13. Preferential T cell expansion by artificial antigen presenting cells expressing 4-1BBL alone or in combination with CD80 or CD86.
Habib-Agahi M; Jaberipour M; Phan TT; Searle PF
Iran J Immunol; 2008 Sep; 5(3):136-47. PubMed ID: 18791280
[TBL] [Abstract][Full Text] [Related]
14. Levels of B7-2 in tumor cells of Hodgkin's disease.
Bosshart H
Immunol Lett; 2004 Apr; 92(3):217-20. PubMed ID: 15081615
[TBL] [Abstract][Full Text] [Related]
15. The B7 family and cancer therapy: costimulation and coinhibition.
Zang X; Allison JP
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5271-9. PubMed ID: 17875755
[TBL] [Abstract][Full Text] [Related]
16. Types I and II interferons upregulate the costimulatory CD80 molecule in monocytes via interferon regulatory factor-1.
Bauvois B; Nguyen J; Tang R; Billard C; Kolb JP
Biochem Pharmacol; 2009 Sep; 78(5):514-22. PubMed ID: 19433065
[TBL] [Abstract][Full Text] [Related]
17. Frontline: Characterization of BT3 molecules belonging to the B7 family expressed on immune cells.
Compte E; Pontarotti P; Collette Y; Lopez M; Olive D
Eur J Immunol; 2004 Aug; 34(8):2089-99. PubMed ID: 15259006
[TBL] [Abstract][Full Text] [Related]
18. Soluble CD276 (B7-H3) is released from monocytes, dendritic cells and activated T cells and is detectable in normal human serum.
Zhang G; Hou J; Shi J; Yu G; Lu B; Zhang X
Immunology; 2008 Apr; 123(4):538-46. PubMed ID: 18194267
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance and regulation of the costimulatory molecule B7-H1 in pancreatic cancer.
Loos M; Giese NA; Kleeff J; Giese T; Gaida MM; Bergmann F; Laschinger M; W Büchler M; Friess H
Cancer Lett; 2008 Sep; 268(1):98-109. PubMed ID: 18486325
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of antigen driven lymphocyte proliferation secondary to GP41-induced B7 expression on adherent monocytes.
Kolber MA; Saenz MO
Cell Immunol; 2001 Nov; 214(1):35-44. PubMed ID: 11902827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
